Execs On The Move: Midmark Gets New Financial Chief; Toxys And CardioFocus Fill Positions In-House
Midmark, a dental and hospital equipment manufacturer, has a new CFO; CardioFocus promoted its president and COO to CEO; Toxys, an in vitro toxicity solutions firm, promoted top executives; and more.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.